NationalLibraryOfScotland/medical-history-of-british-india huggingface dataset:
32
Analysis of 968 hospital charts referring to 484 patients treated with Professor
Lustig's plague curative serum and 484 alternate cases observed as controls, in the
Arthur Road Municipal Plague Hospital, Bombay, under Dr. N. H. Choksy, between
May 1899 and July 1900.
I.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
Number of deat hs.Mort al i t y per-cent age.
Av e r a g e s t a y i n h o s p i t a l b e - f o r e d e a t h ( i n d a y s ) .
Number of pat i ent s.
Number of deat hs.
Mortality per-
centage.
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
I.
State on ad-mission.
T e m p e r a - t u r e :
P a t i e n t s w h o s e f i r s t r e c o r d e d t e m p e r a - t u r e w a s —
Bolow 99°F.
3 7
2 4
6 4 . 8 6
4 . 2 7
4 4
1 1
2 5 . 0
1 . 6 8
99°—100.9°1 0 7
7 1
6 6 . 3 5
3 . 1 6
1 0 7
6 3
5 8 . 8 7
7 . 1 3
101°—102.9°1 8 7
1 5 7
8 3 . 9 5
2 . 6 0
1 8 4
1 3 8
7 5 . 0
3 . 7 4
103° and above.
1 5 3
1 3 3
8 6 . 2 7
2 . 4 0
1 4 9
1 1 8
7 9 . 1 9
3 . 1 3
TOTAL
4 8 4
3 8 5
7 9 . 5 5
2 . 7 6
4 8 4
3 3 0
6 8 . 1 8
3 . 8 9
II.
CONTROL CASES.
TREATED CASES.
Number of pat i ent s.Number of deat hs.Mor t al i t y per - cent age.
A v e r a g e s t a y i n h o s p i t a l b e - f o r e d e a t h ( i n d a y s ) Number of pat i ent s. Number of deat hs.
Mortal i ty per-centage.
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
Pulse and respiration.
1 . Q u i c k p u l s e ( a b o v e 1 0 0 i n a m i n u t e ) w i t h q u i c k r e s p i r a - t i o n ( a b o v e 3 0 i n a m i n u t e ) .
2 2 6
1 8 6
8 2 . 3 4
3 . 0 8
2 8 3
2 0 4
7 2 . 0 8
3 . 6 0
2 . Qu i c k p u l s e wi t h s l o w r e s - p i r a t i o n ( u p t o 3 0 i n a mi n u t e ) .
7 2
5 3
7 3 . 6 1
2 . 8 5
8 1
5 4
6 6 . 6 6
7 . 1 4
I.—contd.
State on ad-mission.
3 . S l o w p u l s e ( u p t o 1 0 0 i n a mi n u t e ) wi t h q u i c k r e s p i r a - t i o n .
2 3
1 4
6 0 . 8 6
7 . 5 3
1 8
7
3 8 . 8 8
7 . 7 1
Pati ents who had on ad-mi ssi on—
4. Sl ow pul se wi t h sl ow res-pi rat i on.
2 4
1 0
4 1 . 6 6
7 . 1 5
4 6
1 2
2 6 . 0 8
4 . 5 8
5. Qui ck pul se wi t h respi rat i on
not recorded.
3
2
6 6 . 6 6
0 . 5 0
5
5
1 0 0 . 0
0 . 1 0
6. Pul se not re-corded wi t h
quick respira
-tion.
2 4
2 4
1 0 0 . 0
0 . 7 0
1 8
1 8
1 0 0 . 0
0 . 3 3
7. Pul se not re-corded wi t h
slow respira-
tion.
3
3
1 0 0 . 0
0 . 5 0
3
3
1 0 0 . 0
0 . 1 6
8. Pul se and r es- pi r at i on not r e- cor ded.
1 0 9
9 3
8 5 . 3 2
1 . 5 4
3 0
2 7
9 0 . 0
1 . 7 9
4 8 4
3 8 5
7 9 . 5 4
2 . 7 6
4 8 4
3 3 0
6 8 . 1 8
3 . 8 9
33
III.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e .
A v e r a g e s t a y i n h o s p i t a l
b e f o r e d e a t h ( i n d a y s ) .
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e .
Ave r a ge s t a y i n hos pi t a l
bef or e deat h ( i n days ) .
I—( contd. )
State on
admis-
sion.
BUBOES:
Patients in
whom bu-
boes were
found on
admission
or later on
to be—
Present
.
.
455
357
78.45 2.77
479
325 68.05
3.80
Single
. . 284
230
80.98 2.12
288
186 64.58
3.14
Maxillary, single .
2
1 50.0
1.50
...
...
...
. . .
Cervical, single .
29
22
75.86 1.68
34
25 73.52
4.30
Axillary, single .
93
81
86.88 1.88
8 0
58 72.50
1. 84
Iliac, single .
.
1
1 100.0 23.50
7
4 57.12
0.87
Inguinal, single .
69
55
79.71 2.38
69
44 63.76
4.11
Femoral, single .
79
63
79.74
1.74
89
49 55.05
2.75
Single in other
situations.
1 1
7
63.63 6.0
9
6 66.66
8.50
Multiple
.
.
171
127
74.26 3.96
191
140 73.29
4.69
Multiple, neigh-
bouring
131
1 0 8 82.44 3.90
149
115 77.18
4.67
Multiple, opposite
20
1 1 55.0
0.90
19
1 1 57.89
2.45
Multiple, scattered
20
8
40.0
8.81
23
14 60.86
4.53
Absent altogether
29
28
96.55 1.71
5
4 80.0
10.62
IV.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n -
t a g e .
A v e r a g e s t a y i n h o s -
p i t a l b e f o r e d e a t h
( i n d a y s ) .
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n -
tage.
A v e r a g e s t a y i n h o s -
p i t a l b e f o r e d e a t h
(in days).
I—( contd.)
State on
admis-
sion.
PREVENTIVE
INOCULA-
TION.
Patients
who had
been pre-
viously—
Inoculated .
.
1 1
5 45.45
2.0
1 1
4 36.36
1.75
Not inoculated
.
473
380 80.33
2.71
473
326 68.92
3.91
F
34
V.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e .
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e .
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
I - ( contd.
) S t a t e o n
admis-
sion.
Sex, Age,
Caste, Na-
tionality.
Among the
patients
there were—
Males .
.
.
354
278 78.53
2.71
351
242 68.94 3.88
Up to 15 years of
age.
52
30 57.69
1.41
63
37 58.73
3.41
16 to 20
. .
64
50 78.12 3.02
60
45 75.0
5.21
21 to 40
.
.
213
178 83.56 2.62
189
130 68.83 3.20
Above 40
.
.
25
20
8 0 . 0
4.62
39
30 76.92
5.40
Females
.
.
130
107 82.30
2.62
133
88 66.16 3.88
Up to 15 years of
age.
51
40 78.43
2.67
39
20 51.28 4.80
16 to 20
.
.
19
15 70.94 1.16
21
14 66.66 5.25
21 to 40
.
51
45 88.23
3.18
55
39 70.09
3.76
Above 40
.
.
9
7 77.77
1.92
1 8
15 83.33 1.73
Hindoos
.
. 410
330 80.48 2.46
408
284 69.58 3.51
Low caste Hindoos
145
1 1 1 76.55
1.95
134
85 63.43 3.45
Other Hindoos
. 265
219 82.64 2.31
274
199 72.62 4.09
Mahomedans
.
27
20 74.07
7.15
21
14 66.66 3.46
Goanese and Native
Christians.
37
27 72.97
1.72
37
20 54.05 4.40
Parsis .
.
.
6
5 83.33
6.30
8
6 75.0
2 0
Europeans and Eu-
rasians.
4
3 75.0
0.66
1 0
6 60.0
4.50
VI.
Serum Cases.
II.
A.
Number of patients with an admission
temperature of 100° F. and over,
who were treated with serum
immediately on admission and
r e c o v e r e d .
B.
Number of A whose temperature
came down after the first injec-
tion of serum and did not
again reach the level of admission
temperature.
C
. P e r c e n t a g e o f
B. to A.
Condition of pa-
tients after firs
application of
treatment and
of their con-
trols.
* Morning admissions
.
52
18
34.61
†
Evening admissions
.
41
21
51.2I
TOTAL
.
93
39
41.93
(*) Morning admissions=those patients whose first temperature was taken in the morning.
(†) Evening admissions=those patients whose first temperature was taken in the evening.
35
Serum Cases — contd..
II.—contd.
Condition of pa-
tients after first
application of
treatment and
of their con-
trols.
A.
Number of patients with an admission
temperature of 100° F. and over,
who were treated with serum
immediately on admission and lived
for more than 24 hours but
eventually died.
B.
Number of A whose temperature
came down after the first injecti
on of serum and did not again
reach the level of admission
temperature.
C.
Percentage of
B. to A.
Morning admissions
.
107
24
22.42
Evening admissions
.
54
8
14.81
TOTAL
.
161
32
19.87
Control Cases.
A.
Number of patients with an admission
temperature of 100º F. and over,
and who eventually
recovered.
B.
Number of A whose temperature
came down within 24 hours of
admission and did not again
reach the level of admis-
sion temperature.
C.
Percentage of
B. to A.
Morning admissions .
.
Evening admissions
.
44 2 6
9
13
20.45
50.0
TOTAL
70
22
31.42
A.
Number of patients with an admission
temperature of 100º F. and over, who
lived for more than 24 hours
after admission but
eventually died.
B.
Number of A whose temperature
came down within 24 hours of
admission and did not again
reach the level of admission
temperature.
C.
Percentage of
B. to A.
Morning admissions
.
107
15
1 4 . 0 1
Evening admissions
.
79
24
30.37
TOTAL
.
186
39
20.96
VII.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e . Av e r a g e s t a y i n h o s -
p i t a l b e f o r e d e a t h ( i n d a y s ) .
N u m b e r o f p a t i e n t s .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e . Av e r a g e s t a y i n h o s -
p i t a l b e f o r e d e a t h ( i n d a y s ) .
Temperature:
(a) Within 24
hours.
339
281 82.92
1.87
324
246 75.93 2.44
III.
Patients admit-
ted with tem-
perature of 99°F
. and above,
in whom the
temperature,
after the first
application of
treatment (or in
controls after
admission),
reached maxi-
mum—
(b) Later than
24 hours.
1 0 8
8 0
74.07 5.48 116
73 62.93
9.05
Condition
during
treat-
ment.
(I treated reco-
very case count-
ed in " within
24 hours," as
the record
shows doubtful
return.)
Proportion of ( b)
to (a ).
31.86
p.cent.
...
. . .
. . .
35.80
p. cent.
. . .
. . .
. . .
F 2
36
VIII.
Temperature of twenty patients who recovered (treated and controls) who
had the highest admission temperature, and average interval between the first
application of treatment or admission to hospital and the time when temperature
became for the first time permanently normal :—
CONTROL CASES.
SERUM CASES.
Number
of
patients.
Admission
temperature.
Number of days after
admission in which
normal temperature
became permanent.
Number
of
patients.
Admission
temperature.
Number of days after
admission in which
normal temperature
became permanent.
I I I . —
c o n t d .
C o n d i t i o n d u r i n g t r e a t m e n t .
1
105°—105.9°12
1 105°—105.9°3
1 , ,
36
1
, ,
22
1
I04°—104.9°1 1
1
, ,
26
1
, ,
14
1
, ,
12
1 , ,
24
1 104º—104.9°9
1
, ,
26
1
, ,
25
1 , ,
8
1
, ,
44
1 , ,
1 9
1
, ,
15
1 , ,
2
1
, ,
14
1 , ,
4
1
, ,
47
1
103°—103.9°1 1 1
, ,
41
1 , ,
73
1
,,
4 1
1 ,,
15
1 103°—103.9°1
1, ,
17
1
, ,
14
1
, ,
20
1
, ,
1
1 , ,
1 1
1
, ,
35
1
, ,
12
1
, ,
2
1
, ,
17
1
, ,
16
1
, ,
34
1
, ,
33
1
,,
33
1
, ,
29
Average interval
19.95
Average interval
21.05
37
REPORT ON A SERIES OF 110 CASES OF PLAGUE TREATED WITH
TERNI'S ANTI-PLAGUE SERUM.
BY W. M. HAFFKINE, C.I.E.,
Director-in-Chief, Plague Research Laboratory,
AND
C. T. COSTELLO, M.B., B.Ch., B.A. (Dublin),
Attached to the Laboratory.
T HE patients treated were those admitted to the Modikhana Municipal
Plague Hospital, Bombay, between November 1902 and July 1903. This
hospital was under the charge of Dr. D. A. Turkhud, M.B., C.M. (Edin.), and the
ordinary symptomatic treatment of the cases was carried out by him.
The serum employed was supplied by Professor Terni of Messina and sent
for trial through the Secretary of State for India. It was sent out in 10 c.c.
bottles, which is presumably the average dose to be given at one time. In reply
to an enquiry Professor Terni informed one of us (W. M. Haffkine), that he
considered the application of his treatment to some 300 patients would prove
its utility, and accordingly sent the requisite amount of serum for this purpose ;
viz., 1,500 bottles, or an average of 5 bottles, or 50 c.c., for each patient. Four
patients received less than this amount (vide Table V) because they died before
the full quantity could be administered ; 42 received 50 c.c. or the prescribed
amount and the rest (65) were given more than this quantity, receiving from
60 to 130 c.c. or above. All were injected hypodermically. The injections were
carried out by one of us (C. T. Costello) at the hospital and he also watched
the patients and compiled the returns from which the subsequent analysis was
made.
The method of selecting the cases was the alternate plan, modified as
follows :—
Every alternate patient was treated with Terni's serum unless he—
(a) objected to such treatment,
(b) was manifestly convalescent,
(c) was manifestly moribund, or
(d) was proved to be suffering from some disease other than plague.
38
The number treated with serum was 111, and the number admitted alter-
nately with them was 112. The hundred and twelfth patient (who recovered)
not being required, is omitted from the subsequent analysis. Further, the chart
of control patient No. 105 having been mislaid in the hospital, it is necessary
to omit the corresponding serum-treated case. The number dealt with below
is therefore reduced to 110 cases in each category.
When patients coming under the headings ( a), (b ), (c), (d), noted above, were
received, they were passed over, and the next admission taken for treatment
with or without serum, as the list demanded.
The following is the general result of the analysis of the tables below.
The mortality in the two groups was practically equal, i.e., 89 deaths
among 110 cases treated with serum, 90 deaths among 110 not so treated.
The serum-treated cases lived on the average about 8 hours longer than
those not treated, vide Table I.
The good effects one would expect from an early administration of the
remedy are not consistently apparent in Table I.
Similarly inconsistent results are seen in Table II. where patients are grouped
according to the apparent severity of the disease. The serum appears to have
benefited the severer cases, but not those of a milder type.
Taking the first recorded temperature of the patients as a guide, it is found
in the control group that the higher this is, the greater is the death-rate among
them. But the serum showed most success in those with a temperature between
101° and 102.9° F., and least in those whose temperature on admission ranged
between 99° and 100.9°.
There is no such inconsistency when we consider the patients from the
point of view of the pulse and respirations recorded on admission.
The figures referring to the presence or absence of buboes or their posi-
tion are small, but where they are considerable (single axillary, femoral or
inguinal buboes), the result is not consistent. The groups to which the less
fatal cases belong do not show improved results under serum treat-
ment.
In the table setting forth the age-distribution, the control cases show the
greatest mortality in those above 25 years of age, but it is just in these cases
that the serum seems to have had best effect, while in patients below that age,
where the untreated cases had a lessened mortality, the serum seems to have
failed.
From Table III it seems that the first application of serum had some
effect in reducing the temperature and pulse-rate within 24 hours after admission ;
39
but unfortunately the mortality appears higher among the treated than among the
controls. The injections appear also to have reduced slightly the number of
respirations per minute.
Table IV shows that the injections tend to reduce the temperature, pulse
and respiration at an earlier date than in the case of the controls, though the mor
-tality is not favourably affected.
Table V shows that the results are not improved by increasing the initial
dose, nor by increasing the total amount of serum given.
Those receiving more than 20 c.c. show the highest mortality. There is
thus no reason to suppose that better results would be obtained by giving doses
larger than those recommended by Professor Terni.
In the year 1904 observations were made on 16 cases of plague admitted
to the Maratha Plague Hospital of the Bombay Municipal Corporation.
These were treated hypodermically with Terni's serum in large doses,
several hundred c.c. being given in some cases. A similar number of plague
cases admitted alternately with them were observed as controls.
The results are shown below :—
Number.
Deaths.
Mortality per cent.
Serum-treated cases
.
.
16
12
75.0
Control cases
.
16
1 1
68.75
40
Analysis of 220 clinical charts referring to 110 plague patients treated with Professors
Term and Bandi's curative serum, and 110 alternate cases observed as controls, in
the Modikhana Municipal Plague Hospital, Bombay, under Dr. Turkhud, between
November 1902 and July 1903.
I.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s
Number of deaths
M o r t a l i t y p e r c e n t a g e
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s )
Number of patients
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
I.
P r e v i o u s H i s t o r y
— P a t i e n t s w h o s t a t e d t h e y h a d b e e n i l l b e f o r e a d m i s s i o n f o r —
One day . . .
1 0
8
8 0
2 . 2 5
8
5
6 2 . 5 0
1 . 2 0
Two days . . .
3 1
2 6
8 3 . 8 7
2 . 5 1
3 4
3 0
8 8 . 2 3
3 . 7 0
Three days . . .
2 8
2 3
8 2 . 1 4
2 . 7 6
1 8
1 1
6 1 . 1 1
3 . 5 4
More than three days .
3 4
2 6
7 6 . 4 7
4 . 0 5
4 3
3 6
8 3 . 7 2
3 . 2 5
An unknown time .
7
7
1 0 0
1 . 5 0
7
7
1 0 0
2 . 6 4
T o t a l o f p a t i e n t s a d m i t - t e d
1 1 0
9 0
8 1 . 8 1
2 . 9 3
1 1 0
8 9
8 0 . 9 0
3 . 2 7
I I .
CONTROL CASES.
TREATED CASES,
N u m b e r o f p a t i e n t s
N u m b e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
N u m b e r o f p a t i e n t s
N u m b e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e
A v e r a g e s t a y i n h o s p i - t a l b e f o r e d e a t h ( i n d a y s )
II.
State on admission.
—
General condition of
patients,
Drowsy, Coma-
tose or un-c o n s c i o u s
19
19
1 0 0 . 0
1.34
24
21
87.50
I.76
Not in above
condition.
91
71
78.02
3.36
86
68
79.06
3.74
'
Temperature.
Patients who had on
admission a tem-
perature of—
Below 99°F
6
6
1 0 0
3.33
1 1
8
72.72
4.18
99º—100.9º.
20
15
75.0
3.10
22
19
86.36
2.63
101º—102.9° .
52
41
78.84
3'30
44
33
75.0
3'66
103º—104.9º
31
27
87.09
2.29
29
25
86.20
3.02
Above 105º
1
1
1 0 0
0 . 5 0
4
4
1 0 0
2.62
TOTAL
.
1 1 0
90
81.81
2.93
110
89
80.90
3.27
Pulse-rate.
Patients whose pulse
on admission was,
per minute-
go and below .
2
2
1 0 0
5.75
2
1
50.0
0 . 5 0
91—120
.
64
50
78.12
3.30
53
41
77.35
4.86
121—15o
41
35
8 5 . 3 6
2 . 2 5
51
43
8 4 . 3 1
1.82
Above 151
.
3
3 100
3.0
4
4 100
3.25
TOTAL
.
1 1 0
90
81.81
2.93
1 1 0
89
80.90
3.27
Respiration.
Patients whose res-
piration on ad-
mission was, per
minute—
35 and less
.
70
57
81.42
3.07
77
60
77.92
3.59
36—50 .
.
36
30
83.33
2.80
33
29
87.87
87
Above 51
.
4
3
75.0
1.66
...
...
...
. . .
TOTAL
110
9 0
81.81
2.93
1 1 0
89
80.90
3.27
41
I I .
—
c o n t d .
CONTROL CASES.
TREATED CASES.
I
N u m b e r o f p a t i e n t s
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s ) .
N u m b e r o f p a t i e n t s
N u m b e r o f D e a t h s .
M o r t a l i t y p e r c e n t a g e .
A v e r a g e s t a y i n h o s p i t a l b e f o r e d e a t h ( i n d a y s )
II—contd.
State on Admission
—contd.
Present .
.
97
8 1
83.50
2.95
102
82
80.39
3.24
Single
.
.
82
66
80.48
2.40
76
59
77.63
2.65
Maxillary, single
2
2 100
2.75
. . .
. . .
. . .
. . .
Cervical,
„
7
7 100
3.50
5
5
100
6.30
Buboes.
Patients in whom
buboes were found,
on admission, or
later, to be—
Parotid
,,
1
1
1 0 0
1.50
1
0
0
...
Axillary
„
21
1 8 85.71
2.05
26
19
73.07
1.89
Inguina
,,
1 8
1 1
6 1 . 1 1
2.40
12
1 1
91.66
1 . 9 5
Femoral
„
31
26
83.87
2.17
32
24
75.0
2.64
In other situa-
tions single.
2
1
50
0.0
...
. . .
. . .
. . .
Multiple . .
15
15 100
5.33
26
23
88.46
5.19
,,
neigh-
bouring.
9
9 100
3.88
17
16
94.11
3.22
,,
opposite
1
1
1 0 0
1.0
2
2
100.0
1 . 2 5
,, scattered
5
5 100
8.90
7
5
71.42
1 1 . 0
Absent altogether
13
9
69.23
3.61
8
7
8 7 . 5 0
4.35
Sex, age, caste, and
nationality.
Among the patients
there were—
Males
. .
90
78
8 0 . 1 1
3.04
102
83
8 1 . 3 7
3.30
Females .
.
20
17
8 5 . 0
2.50
8
6
75.0
2.91
Up to 10 years
of age.
8
5
62.50
1 . 7 0
5
4
8 0 . 0
7 . 7
5
11–25
. .
61
48
78.68
3.34
59
48
81.35
2.96
26–45 years of
age.
38
34
8 9 . 4 7
2.58
39
32
8 2 . 0 5
3.21
Above 45
.
3
3
1 0 0 . 0
2.50
7
5
71.42
3.0
Hindus .
.
75
61
8 1 . 3 4
2.54
74
65
87.83
3.23
Mahomedans .
15
12
8 0 . 0
4.87
13
9
69.23
1 . 9 4
Goanese and
Native Chris-
tians.
17
16
94.11
3.15
21
15
71.42
4.23
Parsis
.
.
3
1
33.33
0.50
2 ...
. . .
...
Europeans and
Eurasians.
. . .
...
. . .
. . .
. . .
. . .
. . .
. . .
42
III.
CONTROL CASES.
TREATED CASES.
Number of pat i ent s T h i e r p r o p o t i o n t o t o t a l ( p e r c c e n t )
Nu mb e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e
A v e r a g e o f i n c r e a s e o r d e c r e a s e .
N u m b e r i n p a t i e n t s
T h e i r p r o p o r t i o n t o t o t a l ( p e r c e n t ) .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e . A v e r a g e e x t e n t i n c r e a s e o r d e c r e a s e .
I I I
.
Condition of patients after
first application of treat-
ment.
Duration of Life.
Died within 24 hours of ad-
mission
. . .
. . . . . . .
1 8
1 6 . 3 6 18
1 0 0 ... 19 17.27 19 100.0 . . .
Lived for more than 24
hours .
.
.
.
.....
92 83.63 72 78.28 ... 91 82.72 70 76.92 ...
Temperature.
Total admitted with 100º F.
and over, who lived for
more than 24 hours
.
. . . . . .
83
...
64
7 7 . 1 0 ...
79
...
63 79.74 . . .
Patients admitted with
temperature above 100º
F. in whom the next
temperature recorded
after treatment (or in
controls after admis-
sion), showed—
Increase .
. 41 49.40 36 87.80 1.5 32 40.50 28 87.50 1.6
Decrease .
. 38 45.78 26 68.42 1.5 46 58.22 34 73.69 1.9
Stationary con-
dition
.
.
4
4.81
2 50.0
...
1
1.26
1
1 0 0 . 0 ...
Pulse.
Total admitted with pulse
above ico a minute, who
lived for more than 24
hours
.
. . .
......
86
...
68 79.06 ... 84
...
67 79.76 ...
Patients admitted with
pulse above too a minute,
in whom the next num-
ber recorded after
treatment (or in con-
trols, after admission)
showed
Increase .
51 59.3o 42 82.35 14 36 42.97 32 88.88 15
Decrease .
28 32.55 19 87.85 16 39 46.42 28 71.79 12
Stationary con-
dition
.
7
8.13
7
1 0 0 . 0 ...
9 10.71
7 77.77 . . .
43
I I I
—
c o n t d .
CONTROL CASES.
TREATED CASES.
Nu mb e r o f p a t i e n t s
T h e i r p r o p o r t i o n t o t o t a l ( p e r c e n t ) .
Nu mb e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e A v e r a g e e x t e n t o f i n - c r e a s e o r d e c r e a s e . Nu mb e r o f p a t i e n t s T h e i r p r o p o r t i o n t o t o t a l ( p e r c e n t ) .
N u m b e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e
A v e r a g e e x t e n t o f i n c r e a s e o r d e c r e a s e .
III—contd.
Condition of patients after
first application of treat-
men t—contd.
Respiration.
Total admitted with more
than 28 a minute who
lived fo more than 24
hours
.
.
. .
......
36
...
68
79.06 ... 85
...
68
80.0
. . .
Patients admitted with
more than 28 in a
minute in whom the
next number recorded
after treatment (or in
controls, after admission)
showed
Increase .
. 49 56.97 42 85.71
6 47 55.29 41
87.23
5
Decrease.
. 30 34 .
21 70.0
5
31 36.47 23 74.19
4
Stationary con-
dition
.
.
7
8.13
5 71.42 ...
7
8.23
4
57.14
. . .
IV.
CONTROL CASES.
TREATED CASES.
N u m b e r o f p a t i e n t s .
T h e i r p r o p o r t i o n t o t o t a l ( p e r c e n t ) .
N u m b e r o f d e a t h s .
M o r t a l i t y p e r c e n t a g e
N u m b e r o f p a t i e n t s .
T h e i r p r o p o r t i o n t o t a t a l ( p e r c e n t ) .
N u m b e r o f d e a t h s
M o r t a l i t y p e r c e n t a g e
IV.
Condition of patients
throughout the trea-
m e n t .
TOTAL
.
57
...
38
...
63
...
44
. . .
Temperature.
Patients admitted
with temperature
above 100° F., who
lived for more than
48 hours, and in
whom the tem-
perature after the
first application of
treatment (or, in
controls, after
admission), reach-
ed maximum.
Within 24 hours
15 26.31
9
60.0
24 38.09
15
62.50
Later than 24
hours
.
.
42 73.68
29
69.04
39 61.90
29
74.35
G 2